{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:09:27Z","timestamp":1786118967220,"version":"build-2736575974"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1097\/jcp.0b013e3181855cd6","type":"journal-article","created":{"date-parts":[[2008,9,12]],"date-time":"2008-09-12T07:01:02Z","timestamp":1221202862000},"page":"485-493","source":"Crossref","is-referenced-by-count":57,"title":["Atypical Antipsychotics, Neurocognitive Deficits, and Aggression in Schizophrenic Patients"],"prefix":"10.1097","volume":"28","author":[{"given":"Menahem I.","family":"Krakowski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pal","family":"Czobor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen A.","family":"Nolan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-3-20210128","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1176\/ajp.153.3.321","article-title":"What are the functional consequences of neurocognitive deficits in schizophrenia?","volume":"153","author":"Green","year":"1996","journal-title":"Am J Psychiatry"},{"key":"R2-3-20210128","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/00005053-199004000-00006","article-title":"Neuropsychological deficits and violent behavior in incarcerated schizophrenics.","volume":"178","author":"Adams","year":"1990","journal-title":"J Nerv Ment Dis"},{"key":"R3-3-20210128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.schres.2004.08.001","article-title":"A neuropsychological investigation into violence and mental illness.","volume":"74","author":"Barkataki","year":"2005","journal-title":"Schizophr Res"},{"key":"R4-3-20210128","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1176\/appi.ajp.158.2.176","article-title":"Studies of cognitive change in patients with schizophrenia following novel antipsychotic treatment.","volume":"158","author":"Harvey","year":"2001","journal-title":"Am J Psychiatry"},{"key":"R5-3-20210128","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1017\/S146114570500516X","article-title":"A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia.","volume":"8","author":"Woodward","year":"2005","journal-title":"Int J Neuropsychopharmacol"},{"key":"R6-3-20210128","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1093\/oxfordjournals.schbul.a033374","article-title":"The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: a review and meta-analysis.","volume":"25","author":"Keefe","year":"1999","journal-title":"Schizophr Bull"},{"key":"R7-3-20210128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.schres.2005.07.038","article-title":"One-year double-blind study of the neurocognitive efficacy of olanzapine, risperidone, and haloperidol in schizophrenia.","volume":"81","author":"Keefe","year":"2006","journal-title":"Schizophr Res"},{"key":"R8-3-20210128","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1001\/archpsyc.64.6.633","article-title":"Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial.","volume":"64","author":"Keefe","year":"2007","journal-title":"Arch Gen Psychiatry"},{"key":"R9-3-20210128","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1176\/appi.ajp.159.6.1018","article-title":"Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder.","volume":"159","author":"Bilder","year":"2002","journal-title":"Am J Psychiatry"},{"key":"R10-3-20210128","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0920-9964(00)00112-2","article-title":"Effects of olanzapine and other antipsychotics on cognitive function in chronic schizophrenia: a longitudinal study.","volume":"48","author":"Cuesta","year":"2001","journal-title":"Schizophr Res"},{"key":"R11-3-20210128","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1017\/S146114570100253X","article-title":"The effects of olanzapine on neurocognitive functioning in medication-refractory schizophrenia.","volume":"4","author":"Smith","year":"2001","journal-title":"Int J Neuropsychopharmacol"},{"key":"R12-3-20210128","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1016\/j.pnpbp.2006.06.001","article-title":"Differential effects of haloperidol, clozapine and olanzapine on learning and memory functions in mice.","volume":"30","author":"Hou","year":"2006","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"R13-3-20210128","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S0278-5846(02)00221-X","article-title":"The effect of chronic treatment with typical and atypical antipsychotics on working memory and jaw movements in three- and eighteen-month-old rats.","volume":"26","author":"Rosengarten","year":"2002","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"R14-3-20210128","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0920-9964(00)00033-5","article-title":"Practice-related improvements in information processing with novel antipsychotic treatment.","volume":"46","author":"Harvey","year":"2000","journal-title":"Schizophr Res"},{"key":"R15-3-20210128","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1001\/archpsyc.63.6.622","article-title":"Atypical antipsychotic agents in the treatment of violent patients with schizophrenia and schizoaffective disorder.","volume":"63","author":"Krakowski","year":"2006","journal-title":"Arch Gen Psychiatry"},{"key":"R16-3-20210128","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s11126-007-9058-7","article-title":"Reducing inpatient aggression: does paying attention pay off?","volume":"79","author":"Nolan","year":"2008","journal-title":"Psychiatr Q"},{"key":"R17-3-20210128","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1097\/00005053-198809000-00007","article-title":"Profiles of aggression among psychiatric patients. I. Nature and prevalence.","volume":"176","author":"Kay","year":"1988","journal-title":"J Nerv Ment Dis"},{"key":"R18-3-20210128","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia.","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr Bull"},{"key":"R19-3-20210128","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"Mini-mental state: a practical method for grading the cognitive state of patients for the clinician.","volume":"12","author":"Folstein","year":"1975","journal-title":"J Psychiatr Res"},{"key":"R20-3-20210128","first-page":"233","article-title":"Extrapyramidal symptom rating scale.","volume":"7","author":"Chouinard","year":"1980","journal-title":"Can J Neurol Sci"},{"key":"R21-3-20210128","first-page":"27","article-title":"Cognitive effects of olanzapine treatment in schizophrenia.","volume":"6","author":"McGurk","year":"2004","journal-title":"MedGenMed"},{"issue":"suppl B","key":"R22-3-20210128","first-page":"88","article-title":"The effects of clozapine on neurocognition: an overview.","volume":"55","author":"Goldberg","year":"1994","journal-title":"J Clin Psychiatry"},{"key":"R23-3-20210128","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/0006-3223(93)90043-D","article-title":"Improvement in cognitive functions and psychiatric symptoms in treatment-refractory schizophrenic patients receiving clozapine.","volume":"34","author":"Hagger","year":"1993","journal-title":"Biol Psychiatry"},{"key":"R24-3-20210128","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/00004714-200006000-00004","article-title":"Anticholinergic differences among patients receiving standard clinical doses of olanzapine or clozapine.","volume":"20","author":"Chengappa","year":"2000","journal-title":"J Clin Psychopharmacol"},{"key":"R25-3-20210128","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0006-8993(02)03570-9","article-title":"Atypical antipsychotic drugs, quetiapine, iloperidone, and melperone, preferentially increase dopamine and acetylcholine release in rat medial prefrontal cortex: role of 5-HT(1A) receptor agonism.","volume":"956","author":"Ichikawa","year":"2002","journal-title":"Brain Res"},{"key":"R26-3-20210128","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0893-133X(01)00400-6","article-title":"Effects of typical and atypical antipsychotics and receptor selective compounds on acetylcholine efflux in the hippocampus of the rat.","volume":"26","author":"Shirazi-Southall","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"R27-3-20210128","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/schbul\/sbi020","article-title":"A summary of the FDA-NIMH-MATRICS workshop on clinical trial design for neurocognitive drugs for schizophrenia.","volume":"31","author":"Buchanan","year":"2005","journal-title":"Schizophr Bull"},{"key":"R28-3-20210128","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/S0006-3223(02)01370-7","article-title":"The neurocognitive effects of low-dose haloperidol: a two-year comparison with risperidone.","volume":"51","author":"Green","year":"2002","journal-title":"Biol Psychiatry"},{"key":"R29-3-20210128","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/0091-3057(94)90162-7","article-title":"The effects of haloperidol and clozapine on PCP- and amphetamine-induced suppression of social behavior in the rat.","volume":"47","author":"Steinpreis","year":"1994","journal-title":"Pharmacol Biochem Behav"},{"key":"R30-3-20210128","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0031-9384(92)90202-D","article-title":"strong antiaggressive effects with minimal motor impairment.","volume":"51","author":"Garmendia","year":"1992","journal-title":"Physiol Behav"},{"key":"R31-3-20210128","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/BF02246964","article-title":"Subcortical dopamine and serotonin turnover during acute and subchronic administration of typical and atypical neuroleptics.","volume":"110","author":"Csernansky","year":"1993","journal-title":"Psychopharmacology (Berl)"},{"key":"R32-3-20210128","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1126\/science.167.3919.900","article-title":"Lateral hypothalamic control of killing: evidence for a cholinoceptive mechanism.","volume":"167","author":"Smith","year":"1970","journal-title":"Science"},{"key":"R33-3-20210128","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0006-8993(71)90544-0","article-title":"Direct chemical stimulation of the thalamus: effects on aggressive behavior in the rat.","volume":"26","author":"Bandler","year":"1971","journal-title":"Brain Res"},{"key":"R34-3-20210128","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1176\/ajp.155.2.226","article-title":"Violence and severe mental illness: the effects of substance abuse and nonadherence to medication.","volume":"155","author":"Swartz","year":"1998","journal-title":"Am J Psychiatry"},{"key":"R35-3-20210128","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/oxfordjournals.schbul.a007065","article-title":"Effectiveness of atypical antipsychotic medications in reducing violent behavior among persons with schizophrenia in community-based treatment.","volume":"30","author":"Swanson","year":"2004","journal-title":"Schizophr Bull"}],"container-title":["Journal of Clinical Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/JCP.0b013e3181855cd6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:10:54Z","timestamp":1786036254000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00004714-200810000-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/jcp.0b013e3181855cd6","relation":{},"ISSN":["0271-0749"],"issn-type":[{"value":"0271-0749","type":"print"}],"subject":[],"published":{"date-parts":[[2008,10]]}}}